Acadia Pharmaceuticals (ACAD) Exchange Rate Effect (2010 - 2026)
Acadia Pharmaceuticals (ACAD) recorded quarterly Exchange Rate Effect of $25000.0 in Q1 2026, up 257.14% quarter-over-quarter from $7000.0 in Q4 2025, and up 600.0% on a YoY basis from $3571.4 in Q1 2025.
Acadia Pharmaceuticals (ACAD) Exchange Rate Effect (2010 - 2026) Analysis & Trends
Acadia Pharmaceuticals' Exchange Rate Effect history runs 15 years deep, the most recent figure standing at $25000.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect rose 600.0% year-over-year to $25000.0; the TTM figure through Mar 2026 stood at $56000.0 (up 153.85% YoY), while the FY2025 annual figure was $26000.0, up 127.66% from the prior year.
- Exchange Rate Effect was $25000.0 for Q1 2026 at Acadia Pharmaceuticals, up from $7000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $25000.0 in Q1 2026 to a low of -$60000.0 in Q4 2024.
- Historically, Exchange Rate Effect has averaged -$3666.7 across 5 years, with a median of $2000.0 in 2022.
- The sharpest annual moves came in 2024 and 2025: Exchange Rate Effect plunged 950.0% in 2024, then jumped 700.0% in 2025.
- A 5-year view of Exchange Rate Effect shows it stood at -$8000.0 in 2022, then tumbled by 50.0% to -$12000.0 in 2023, then sank by 400.0% to -$60000.0 in 2024, then surged by 111.67% to $7000.0 in 2025, then jumped by 257.14% to $25000.0 in 2026.
- The last three Exchange Rate Effect figures came in at $25000.0 (Q1 2026), $7000.0 (Q4 2025), and $24000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Acadia Pharmaceuticals | 3.68 Bn | 2.83 Bn | 243.27 Mn | 25,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25,000.00 |
| Mar 31, 2026 | 25,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Jun 30, 2025 | 24,000.00 |
| Jun 30, 2025 | 24,000.00 |
| Mar 31, 2025 | -5,000.00 |
| Mar 31, 2025 | -5,000.00 |
| Dec 31, 2024 | -60,000.00 |
| Dec 31, 2024 | -60,000.00 |
| Sep 30, 2024 | -42,000.00 |
| Sep 30, 2024 | -42,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Dec 31, 2023 | -12,000.00 |
| Dec 31, 2023 | -12,000.00 |
| Sep 30, 2023 | -4,000.00 |
| Sep 30, 2023 | -4,000.00 |